Coherus Oncology Inc.
CHRS | NASDAQ
$1.27
-$0.10 (-7.30%)
Sep 22, 2026, 1:04 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 108.77M | 465.5M | 446.87M | 154.97M | 179.75M | -172.87M | -13.42M | -42.38M | -71.27M | -59.29M | -237.89M | -217.11M | -264.12M | -271.4M | -291.75M | -278.61M | -230.49M | -210.24M | -287.1M | -231.67M | -165.21M | -76.28M |
Depreciation & Amortization | 5.65M | 4.93M | 5.09M | 4.06M | 4.64M | 4.82M | 5.28M | 5.31M | 4.66M | 4.35M | 3.79M | 3.78M | 3.87M | 3.88M | 3.7M | 4.07M | 3.97M | 3.96M | 4.04M | 4.45M | 4.25M | 4.12M |
Stock-Based Compensation | 21.54M | 21.99M | 24.98M | 20.57M | 24.05M | 18.62M | 20.57M | 24.99M | 28.07M | 38.15M | 43.11M | 44.04M | 46.37M | 50.14M | 50.74M | 39.01M | 38.67M | 36.41M | 40.42M | 50.29M | 47.66M | 45.49M |
Other Working Capital | -157.98M | -174.75M | -194.93M | -95.29M | -115.03M | -79.28M | -57.57M | 7.12M | 79.28M | 154.66M | 136.83M | 46.2M | 1.18M | -42.45M | -40.41M | -7.93M | -34.25M | -12.13M | 13.68M | 19.24M | 36.9M | 23.49M |
Other Non-Cash Items | -277.61M | -593.47M | -580.47M | -302.14M | -294.52M | 71.8M | -88.76M | -57.62M | -58.23M | -98.14M | 52.06M | 4.33M | 30.68M | 33.05M | 75.45M | 87.28M | 66.78M | 58.17M | 162.85M | 156.18M | 153.19M | 166.32M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 874K | 874K | 874K | 874K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -103K | -103K |
Change in Working Capital | -102.26M | -69.52M | -34.98M | 32.36M | -19.79M | 78.13M | 55.89M | 7.73M | 41.64M | -38.86M | -36.83M | -97.81M | -61.49M | -71.49M | -79.26M | -45.25M | -21.63M | 18.85M | 42.36M | 68.76M | 41.87M | 2.48M |
Operating Cash Flow | -243.92M | -170.57M | -138.51M | -90.19M | -105.87M | 500K | -20.44M | -61.99M | -54.27M | -152.92M | -174.88M | -261.9M | -244.69M | -255.81M | -241.12M | -193.49M | -142.69M | -92.84M | -37.43M | 48.01M | 81.66M | 142.04M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -34K | -34K | -134K | -286K | -339K | -796K | -1.58M | -2.04M | -2.42M | -2.22M | -1.76M | -1.29M | -1.77M | -3.62M | -5.59M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 76K | 227K | 667K | 845K | 769K | 618K | 178K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -109.79M | -110.23M | -103.84M | -89.58M | -20.73M | n/a | n/a | n/a | n/a | -19.51M | -19.69M | -147.07M | -147.07M | -127.56M | -127.38M | -10.71M | -42.16M | -42.16M | -182.49M | -171.78M | -182.31M | -414.18M |
Sales Maturities Of Investments | 141.27M | 59.6M | 21.46M | 1.65M | n/a | n/a | 14.89M | 51.1M | 94.5M | 155.03M | 157.64M | 121.43M | 78.03M | 17.5M | n/a | 118.66M | 166.36M | 166.36M | 166.36M | 47.7M | 63M | 63M |
Other Investing Acitivies | -10.61M | 473.86M | 457.46M | 465.31M | 465.78M | 10.07M | 215.43M | 214.92M | 221.48M | 193.82M | 6.12M | 4.75M | -2.25M | -2.25M | -37.43M | -35M | -35M | -11M | -121M | 90.01M | 87.51M | 58.51M |
Investing Cash Flow | 20.88M | 423.23M | 375.09M | 377.38M | 445.05M | 10.07M | 230.32M | 266.07M | 316.17M | 329.88M | 144.64M | -20.46M | -71.46M | -113.71M | -166.85M | 70.54M | 86.99M | 111.45M | -138.41M | -35.84M | -35.43M | -298.26M |
Debt Repayment | n/a | -233.19M | -233.19M | -456.59M | -233.33M | -223.41M | -223.41M | n/a | -223.27M | n/a | n/a | n/a | 49.49M | 49.49M | 49.93M | 49.26M | -232K | -232K | -672K | n/a | -674K | 222.16M |
Common Stock Repurchased | -3K | -3K | -267K | -267K | -264K | -264K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.66M | -2.66M | -2.66M | -2.66M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 51K | -48.56M | -48.5M | 173.42M | -48.56M | 34.67M | 34.05M | -188.42M | 33.23M | -2.05M | -4.47M | -3.71M | -4.07M | -4.44M | -1.05M | -811K | -289K | 500K | -1.75M | 3.29M | 8.23M | -4.02M |
Financial Cash Flow | 115.41M | -219.85M | -273.71M | -281.56M | -281.72M | -188.13M | -186.97M | -186.84M | -175.57M | 66.68M | 69.6M | 75.83M | 113.59M | 59.99M | 54.33M | 49.22M | 1.45M | 47.59M | 51.88M | 55.91M | 58.89M | 222.46M |
Net Cash Flow | -107.61M | 32.83M | -37.11M | 5.66M | 57.46M | -177.55M | 22.91M | 16.79M | 85.88M | 243.19M | 38.9M | -206.53M | -202.56M | -309.54M | -353.65M | -73.74M | -54.25M | 66.19M | -123.96M | 68.07M | 105.12M | 66.24M |
Free Cash Flow | -243.92M | -170.57M | -138.51M | -90.19M | -105.87M | 500K | -20.44M | -62.02M | -54.3M | -153.05M | -175.17M | -262.24M | -245.49M | -257.39M | -243.16M | -195.91M | -144.92M | -94.6M | -38.72M | 46.24M | 78.03M | 136.44M |
Adj. Free Cash Flow | -265.45M | -192.56M | -163.49M | -110.76M | -129.91M | -18.12M | -41.01M | -87M | -82.37M | -191.2M | -218.28M | -306.28M | -291.85M | -307.53M | -293.9M | -234.92M | -183.59M | -131.02M | -79.14M | -4.05M | 30.37M | 90.95M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100K | -252K | -339K | -796K | -1.58M | -2.04M | -2.42M | -2.22M | -1.76M | -1.29M | -1.77M | -3.5M | -3.09M |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -34K | -34K | -34K | -34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -123.37K | -2.51M |
Owner Earnings | -243.92M | -170.57M | -138.51M | -90.19M | -105.87M | 500K | -20.44M | -61.99M | -54.27M | -153.02M | -175.14M | -262.24M | -245.49M | -257.39M | -243.16M | -195.91M | -144.92M | -94.6M | -38.72M | 46.24M | 78.16M | 138.95M |
Add to Watchlist
Select watchlists to add or remove CHRS